GxP Lifeline
  • How Northeast Scientific leverages MasterControl’s Medical Device Manufacturing execution software.

    Vision and Paperless Manufacturing Operations Make Northeast Scientific a Medical Device Industry Leader

    Many medical device manufacturing businesses are busily exploring ways to reduce the soaring costs of health care. Medical device remanufacturer Northeast Scientific is contributing to the effort by repurposing single-use devices (SUDs) to make them fit and safe to reuse.

    Full story
  • Leveraging Digital Manufacturing Solutions

    Human-Centric Digitization in Manufacturing: Optimize, Empower, and Engage Workers

    Manufacturers sometimes make the mistake of viewing automation or digitization in manufacturing as a replacement for workers rather than as a means of supporting and enhancing workers. In failing to invest in digital manufacturing solutions as tools to optimize people on the shop floor, manufacturers miss out on the real benefits of digital transformation, including time efficiencies, new business intelligence, and greater productivity.

    Full story
  • 3 Reasons to adopt a data-centric quality mindset for life sciences.

    3 Reasons You Should Adopt a Data-Centric Quality Mindset

    To improve quality, life sciences companies need to bring that data together, use automated analytics tools, and use artificial intelligence (AI) to improve performance. There are three main ways we’re preparing to help you do that.

    Full story
  • 7 key concepts to understand the FDA’s Quality System Approach for the Pharma Industry.

    7 Key Concepts in the FDA’s Quality System Guidance for Pharma

    These seven concepts are critical to understanding the U.S. Food and Drug Administration’s guidance “Quality Systems Approach to the Pharmaceutical Current Good Manufacturing Practice Regulations.”

    Full story
  • How to reduce human errors in the pharma industry with paperless manufacturing.

    Why Paperless Manufacturing Is Critical to the Pharmaceutical Industry

    In addition to focusing on more resilient supply chains, the pharma industry needs to prioritize ways to reduce human error in manufacturing. Human errors cost time and money, but they are often preventable.

    Full story
  • MasterControl’s Medical device QMS can help comply with medical device quality regulations.

    4 Ways to Prepare for UK Medical Device Regulations (MDRs)

    The United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency (MHRA) recently issued new guidance pertaining to regulated medical devices in the UK. Here’s how to prepare.

    Full story
  • 3 tips to choose a pharma contract manufacturing organization featured by MasterControl

    Three Tips for Pharma Picking a CMO

    Pharmaceutical companies need to partner with contract manufacturers capable of maintaining impeccable product quality. Follow these three tips to find a CMO in the pharma industry that can meet and exceed expectations.

    Full story
  • Supply chain best practices for the medical device industry

    Medical Device Supply Chain Backup

    It pays to have backup plans, and the supply chain is no different. Constantly fluctuating COVID-19 protocols and transportation issues continue to plague the medical device industry, but there are steps that can be taken to deal with these problems.

    Full story
  • MasterControl’s Digital Quality Management System for Pharma Companies to avoid compliance and regulatory mistakes.

    5 Pharma Compliance Mistakes to Avoid

    No pharma company wants to fail an inspection, and yet it’s common for these five mistakes to interfere with compliance efforts. Industry expert Nicole Cannon offers tips on how to avoid them along with insight into how digitization can be part of the solution. Follow her advice to get safe, effective products to market quickly.

    Full story
  • Medical Device Manufacturing Digitization Trends and Best Practices with MasterControl Manufacturing Software

    Medical Device Manufacturing Trends, Part 1: Resilient Supply Chains Require Modern Tools

    While visibility, agility, and responsiveness have been priorities in managing supply chains for decades, the disruption and volatility around the COVID-19 pandemic amplified their critical role. In doing so, it brought to light the need to digitize and integrate supply chain systems to ensure all relevant data and insights can be connected for optimal resiliency. To protect themselves in the face of supply chain volatility, medical device manufacturers should reassess their supply chain capabilities with an eye toward proactive, tech-enabled solutions.

    Full story
  • MasterControl’s Quality Management System: a solution for pharma’s data integrity issues

    Data Integrity in Pharma is Key to Compliance

    The FDA has signaled that data integrity is increasingly central to the drug approval process. Pharma organizations need to take the cue and adopt a quality management system that improves their ability to record and manage data, which will streamline their compliance efforts.

    Full story
  • Medical Device Manufacturing Digital Solution

    Attain the Manufacturing Trifecta: Decrease Expenses, Increase Efficiency, and Accelerate Product Release

    A medical device manufacturer was working across two disparate systems. The result? Mistakes made their way into the manufacturing process, which resulted in lengthy review times, and delayed speed to market. The solution was digitization, and it immediately saved them $42,000 per year.

    Full story
  • Latest Pharmaceutical Manufacturing Trends

    Pharma Manufacturers Are Modernizing to Improve Quality and Safety

    Given the high numbers of pharmaceutical recalls and shortages, along with the current supply chain issues, product manufacturers are making modernization a higher priority. This post examines the new pharmaceutical manufacturing trends in modernization.

    Full story
  • GxP Lifeline, a blog by MasterControl: image of hands scrolling on a tablet with a city background

    Not-To-Be Missed Blog Posts From 2021

    Before 2021 is gone, catch up on our most informative blogs that will help you conquer the challenges you’ll face next year.

    Full story
  • 2021-bl-med-device-quality-trends_132x132

    Small Regulatory Steps for AI in SaMD

    Artificial intelligence (AI) in health care has enormous potential, but AI-enabled software as a medical device (SaMD) is charting new territory. Last year, regulators indicated some of their priorities for AI in SaMD and what regulations might look like in the future.

    Full story
  • 2021-bl-pharma-quality-trends_132x132

    3 Keys to Meeting Pharma Regulators’ Data Expectations

    FDA and other regulators are increasingly cracking down on pharma companies’ data integrity lapses. Learn the fundamentals of maximizing data usage that will help keep your quality and compliance activities aligned with regulatory expectations.

    Full story
  • 2021-bl-personalized-medicine-trends-2_132x132

    3 Ways to Rethink Regulatory Change in Personalized Medicine

    As the field of personalized medicine grows and evolves, and regulatory agencies such as the U.S. Food and Drug Administration (FDA) take steps to address regulatory oversight in the field, affected organizations should brace themselves for change and use it to their advantage. Here are three ways that companies in personalized medicine can approach regulatory obstacles as opportunities instead.

    Full story
  • 2021-bl-annex11-vs-part11_132x132

    Understanding the Differences Between EU’s Annex 11 and FDA’s 21 CFR Part 11

    With manufacturers digitizing at a rapid rate, understanding the core of the European Union’s (EU) guidelines, Annex 11, and its approximate FDA counterpart, 21 CFR Part 11, is more critical than ever. They are central to understanding the conditions for life sciences manufacturers’ electronic data in the EU and the U.S., and while the guidance is similar in both countries, it’s important to understand the key differences.

    Full story
  • 2021-bl-fda-warning_132x132

    Prelude to an FDA Warning Letter

    Receiving a warning letter involves action items and additional correspondence with the U.S. Food and Drug Administration (FDA). All of which delays your company in getting product out the door. Learn some of the common reasons life sciences companies receive FDA warning letters, so you can avoid making the same mistakes.

    Full story
  • 2021-bl-steps-to-capa-success_132x132

    7 CAPA Process Steps to Ensure CAPA Success

    Inadequate quality management and poor data can be costly for a life sciences company or similarly regulated industry. However, a strong corrective action/preventive action (CAPA) program paired with a digital CAPA management tool can help differentiate your company from the competition.

    Full story
[ { "key": "fid#1", "value": ["GxP Lifeline Blog"] } ]